Immunoregulation by microbes and parasites in the control of allergy and autoimmunity

  • Rick M. Maizels
  • Ursula Wiedermann
Part of the Progress in Inflammation Research book series (PIR)


Key changes in our microbial environment, encompassing mycobacteria, helminth worms and commensal microflora, may each have had a major impact on the development and reactivity of our immune system not only to infections, but also in the context of harmless antigens in autoimmunity and allergy. We discuss here recent advances in understanding host-microbe and host-parasite interactions, and their impact on the balance between immunoregulation and immunopathology in the mammalian immune system.


Atopic Dermatitis Experimental Autoimmune Encephalomyelitis Treg Cell Allergy Clin Immunol Respir Crit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347: 911–920PubMedCrossRefGoogle Scholar
  2. 2.
    Fleming JO, Cook TD (2006) Multiple sclerosis and the hygiene hypothesis. Neurology 67: 2085–2086PubMedCrossRefGoogle Scholar
  3. 3.
    Eder W, Ege MJ, von Mutius E (2006) The asthma epidemic. N Engl J Med 355: 2226–2235PubMedCrossRefGoogle Scholar
  4. 4.
    ISAAC (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic exzema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 351:1225–1232CrossRefGoogle Scholar
  5. 5.
    Correale J, Farez M (2007) Association between parasite infection and immune responses in multiple sclerosis. Annals of Neurology 61: 97–108PubMedCrossRefGoogle Scholar
  6. 6.
    Pelosi U, Porcedda G, Tiddia F, Tripodi S, Tozzi AE, Panetta V, Pintor C, Matricardi PM (2005) The inverse association of salmonellosis in infancy with allergic rhinoconjunctivitis and asthma at school-age: a longitudinal study. Allergy 60: 626–630PubMedCrossRefGoogle Scholar
  7. 7.
    Wills-Karp M, Santeliz J, Karp CL (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1: 69–75PubMedCrossRefGoogle Scholar
  8. 8.
    Kamradt T, Göggel R, Erb KJ (2005) Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 26: 260–267PubMedCrossRefGoogle Scholar
  9. 9.
    Schaub B, Lauener R, von Mutius E (2006) The many faces of the hygiene hypothesis. J Allergy Clin Immunol 117: 969–977; quiz 978PubMedCrossRefGoogle Scholar
  10. 10.
    Fleming J, Fabry Z (2007) The hygiene hypothesis and multiple sclerosis. Ann Neurol 61: 85–89PubMedCrossRefGoogle Scholar
  11. 11.
    Martinez FD, Holt PG (1999) Role of microbial burden in aetiology of allergy and asthma. Lancet 354 (Suppl 2): SII12–15Google Scholar
  12. 12.
    Holt PG, Upham JW, Sly PD (2005) Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 116: 16–24PubMedCrossRefGoogle Scholar
  13. 13.
    Strachan DP (1989) Hay fever, hygiene, and household size. BMJmj 299: 1259–1260CrossRefGoogle Scholar
  14. 14.
    Kero J, Gissler M, Hemminki E, Isolauri E (2001) Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol 108: 781–783PubMedCrossRefGoogle Scholar
  15. 15.
    Simpson CR, Anderson WJ, Helms PJ, Taylor MW, Watson L, Prescott GJ, Godden DJ, Barker RN (2002) Coincidence of immune-mediated diseases driven by Th1 and Th2. subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy 32: 37–42PubMedCrossRefGoogle Scholar
  16. 16.
    Sakaguchi S (2004) Naturally arising CD4+ regulatory T cells for immunologic selftolerance and negative control of immune responses. Annu Rev Immunol 22: 531–562PubMedCrossRefGoogle Scholar
  17. 17.
    Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, Maisch S, Carr D, Gerlach F, Bufe A et al (2002) Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347: 869–877PubMedCrossRefGoogle Scholar
  18. 18.
    Leonardi-Bee J, Pritchard D, Britton J (2006) Asthma and current intestinal parasite infection: systematic review and meta-analysis. Am J Respir Crit Care Med 174: 514–523PubMedCrossRefGoogle Scholar
  19. 19.
    Smits HH, Hammad H, van Nimwegen M, Soullie T, Willart MA, Lievers E, Kadouch J, Kool M, Oosterhoud JK, Deelder AM et al (2007) Protective effect of Schistosoma mansoni infection on allergic asthma depends on intensity and chronicity of infection. J Allergy Clin Immunol 120: 932–940PubMedCrossRefGoogle Scholar
  20. 20.
    Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bonnelykke K, Brasholt M, Heltberg A, Vissing NH, Thorsen SV et al (2007) Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 357: 1487–1495PubMedCrossRefGoogle Scholar
  21. 21.
    Smit JJ, Folkerts G, Nijkamp FP (2004) Ramp-ing up allergies: Nramp 1 (Slc1 1a1), macrophages and the hygiene hypothesis. Trends Immunol 25: 342–347PubMedCrossRefGoogle Scholar
  22. 22.
    Matricardi PM, Bonini S (2000) High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the Hygiene hypothesis? Clin Exp Allergy 30: 1506–1510PubMedCrossRefGoogle Scholar
  23. 23.
    von Mutius E, Fritzsch C, Weiland SK, Roll G, Magnussen H (1992) Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. BMJ 305: 1395–1399CrossRefGoogle Scholar
  24. 24.
    Hopkin JM (1999) Early life receipt of antibiotics and atopic disorder. Clin Exp Allergy 29: 733–734PubMedCrossRefGoogle Scholar
  25. 25.
    Foliaki S, Nielsen SK, Bjorksten B, Von Mutius E, Cheng S, Pearce N (2004) Antibiotic sales and the prevalence of symptoms of asthma, rhinitis, and eczema: The International Study of Asthma and Allergies in Childhood (ISAAC) Int J Epidemiol 33: 558–563PubMedCrossRefGoogle Scholar
  26. 26.
    Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G (1999) Atopy in children of families with an anthroposophic lifestyle. Lancet 353: 1485–1488PubMedCrossRefGoogle Scholar
  27. 27.
    Floistrup H, Swartz J, Bergstrom A, Alm JS, Scheynius A, van Hage M, Waser M, Braun-Fahrlander C, Schram-Bijkerk D, Huber M et al (2006) Allergic disease and sensitization in Steiner school children. J Allergy Clin Immunol 117: 59–66PubMedCrossRefGoogle Scholar
  28. 28.
    Riedler J, Braun-Fahrlander C, Eder W, Schreuer M, Waser M, Maisch S, Carr D, Schierl R, Nowak D, von Mutius E (2001) Exposure to farming in early life and development of a sthma and allergy: a cross-sectional survey. Lancet 358: 1129–1133PubMedCrossRefGoogle Scholar
  29. 29.
    Matricardi PM, Rosmini F, Riondino S, Fortini M, Ferrigno L, Rapicetta M, Bonini S (2000) Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 320: 412–417PubMedCrossRefGoogle Scholar
  30. 30.
    Wagner A, Förster-Waldl E, Garner-Spitzer E, Schabussova I, Kundi M, Pollak A, Scheiner O, Joachim A, Wiedermann U (2009) Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice. Int J Parasitol 39: 465–472PubMedCrossRefGoogle Scholar
  31. 31.
    Shirakawa T, Enomoto T, Shimazu S, Hopkin JM (1997) The inverse association between tuberculin responses and atopic disorder. Science 275: 77–79PubMedCrossRefGoogle Scholar
  32. 32.
    von Mutius E, Pearce N, Beasley R, Cheng S, von Ehrenstein O, Bjorksten B, Weiland S (2000) International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 55: 449–453CrossRefGoogle Scholar
  33. 33.
    Herz U, Lacy P, Renz H, Erb K (2000) The influence of infections on the development and severity of allergic disorders. Curr Opin Immunol 12: 632–640PubMedCrossRefGoogle Scholar
  34. 34.
    Smit JJ, Folkerts G, Nijkamp FP (2004) Mycobacteria, genes and the ‘hygiene hypothesis’, Curr Opin Allergy Clin Immunol 4: 57–62PubMedCrossRefGoogle Scholar
  35. 35.
    Andersen E, Isager H, Hyllested K, (1981) Risk factors in multiple sclerosis: tuberculin reactivity, age at measles infection, tonsillectomy and appendectomy. Acta Neurol Scand 63: 131–135PubMedCrossRefGoogle Scholar
  36. 36.
    Sewell DL, Reinke, EK, Hogan LH, Sandor M, Fabry Z (2002) Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol Lett 82: 101–110PubMedCrossRefGoogle Scholar
  37. 37.
    Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G (1998) Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 187: 561–569PubMedCrossRefGoogle Scholar
  38. 38.
    Herz U, Gerhold K, Gruber C, Braun A, Wahn U, Renz H, Paul K (1998) BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 102: 867–874PubMedCrossRefGoogle Scholar
  39. 39.
    Zuany-Amorim C, Manlius C, Trifilieff A, Brunet LR, Rook G, Bowen G, Pay G, Walker C (2002) Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J Immunol 169: 1492–1499PubMedGoogle Scholar
  40. 40.
    Smit JJ, Van Loveren H, Hoekstra MO, Schijf MA, Folkerts G, Nijkamp FP (2003) Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features. Clin Exp Allergy 33: 1083–1089PubMedCrossRefGoogle Scholar
  41. 41.
    Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C (2002) Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 8: 625–629PubMedCrossRefGoogle Scholar
  42. 42.
    Smit JJ, Van Loveren H, Hoekstra MO, Karimi K, Folkerts G, Nijkamp FP (2003) The Slc11a1 (Nramp1) gene controls efficacy of mycobacterial treatment of allergic asthma. J Immunol 171: 754–760PubMedGoogle Scholar
  43. 43.
    Alm JS, Sanjeevi CB, Miller EN, Dabadghao P, Lilja G, Pershagen G, Blackwell JM, Scheynius A (2002) Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471. Genes Immun 3: 71–77PubMedCrossRefGoogle Scholar
  44. 44.
    Rook GA, Adams V, Hunt J, Palmer R, Martinelli R, Brunet LR (2004) Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol 25: 237–255PubMedCrossRefGoogle Scholar
  45. 45.
    Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ et al (1995) CD-1 restricted T cell recognition of microbial lipoglycan antigens. Science 269: 227–230PubMedCrossRefGoogle Scholar
  46. 46.
    Korf JE, Pynaert G, Tournoy K, Boonefaes T, Van Oosterhout A, Ginneberge D, Haegeman A, Verschoor JA, De Baetselier P, Grooten J (2006) Macrophage reprogramming by mycolic acid promotes a tolerogenic response in experimental asthma. Am J Respir Crit Care Med 174: 152–160PubMedCrossRefGoogle Scholar
  47. 47.
    Elliott DE, Summers RW, Weinstock JV (2007) Helminths as governors of immunemediated inflammation. Int J Parasitol 37: 457–464PubMedCrossRefGoogle Scholar
  48. 48.
    Muller R (2002) Worms and Human Disease. CABI Publishing, WallingfordCrossRefGoogle Scholar
  49. 49.
    Maizels RM, Yazdanbakhsh M (2003) Regulation of the immune response by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 3: 733–743PubMedCrossRefGoogle Scholar
  50. 50.
    Taylor M, Le Goff L, Harris A, Malone E, Allen JE, Maizels RM (2005) Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 174: 4924–4933PubMedGoogle Scholar
  51. 51.
    Wilson MS, Taylor M, Balic A, Finney CAM, Lamb JR, Maizels RM (2005) Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 202: 1199–1212PubMedCrossRefGoogle Scholar
  52. 52.
    McSorley HJ, Harcus YM, Murray J, Taylor MD, Maizels RM (2008) Expansion of Foxp3+ regulatory T cells in mice infected with the filarial parasite, Brugia malayi. J Immunol 181: 6456–6466Google Scholar
  53. 53.
    Araujo MI, Lopes AA, Medeiros M, Cruz AA, Sousa-Atta L, Solé D, Carvalho EM (2000) Inverse association between skin response to aeroallergen and Schistosoma mansoni infection. Int Arch Allergy Immunol 123: 145–148PubMedCrossRefGoogle Scholar
  54. 54.
    Nyan OA, Walraven GEL, Banya WAS, Milligan P, Van Der Sande M, Ceesay SM, Del Prete G, McAdam KPWJ (2001) Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities. Clin Exp Allergy 31: 1672–1678PubMedCrossRefGoogle Scholar
  55. 55.
    Cooper PJ, Chico ME, Rodrigues LC, Ordonez M, Strachan D, Griffin GE, Nutman TB (2003) Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol 111: 995–1000PubMedCrossRefGoogle Scholar
  56. 56.
    Dagoye D, Bekele Z, Woldemichael K, Nida H, Yimam M, Hall A, Venn AJ, Britton JR, Hubbard R, Lewis SA (2003) Wheezing, allergy, and parasite infection in children in urban and rural Ethiopia. Am J Respir Crit Care Med 167: 1369–1373PubMedCrossRefGoogle Scholar
  57. 57.
    Medeiros M, Jr., Figueiredo JP, Almeida MC, Matos MA, Araujo MI, Cruz AA, Atta AM, Rego MA, de Jesus AR, Taketomi EA et al (2003) Schistosoma mansoni infection is associated with a reduced course of asthma. J Allergy Clin Immunol 111: 947–951PubMedCrossRefGoogle Scholar
  58. 58.
    Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, Alvarez N (1993) Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 92: 404–411PubMedCrossRefGoogle Scholar
  59. 59.
    van den Biggelaar A, van Ree R, Roderigues LC, Lell B, Deelder AM, Kremsner PG, Yazdanbakhsh M (2000) Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356: 1723–1727PubMedCrossRefGoogle Scholar
  60. 60.
    van den Bigglaar AH, Rodrigues LC, van Ree R, van der Zee JS, Hoeksma-Kruize YC, Souverijn JH, Missinou MA, Borrmann S, Kremsner PG, Yazdanbakhsh M (2004) Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 189: 892–900CrossRefGoogle Scholar
  61. 61.
    Araujo MIAS, Hoppe B, Medeiros M Jr, Alcântara L, Almeida MC, Schriefer A, Oliveira RR, Kruschewsky R, Figueiredo JP, Cruz AA et al (2004) Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J Infect Dis 190: 1797–1803PubMedCrossRefGoogle Scholar
  62. 62.
    Lynch NR, Palenque M, Hagel I, Di Prisco MC (1997) Clinical improvement of asthma after anthelmintic treatment in a tropical situation. Am J Respir Crit Care Med 156: 50–54PubMedGoogle Scholar
  63. 63.
    Cooper PJ, Chico ME, Bland M, Griffin GE, Nutman TB (2003) Allergic symptoms, atopy, and geohelminth infections in a rural area of Ecuador. Am J Respir Crit Care Med 168: 313–317PubMedCrossRefGoogle Scholar
  64. 64.
    Summers RW, Elliott DE, Qadir K, Urban JF, Jr., Thompson R, Weinstock JV (2003) Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 98: 2034–2041PubMedCrossRefGoogle Scholar
  65. 65.
    Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV (2005) Trichuris suis therapy in Crohn’s disease. Gut 54: 87–90PubMedCrossRefGoogle Scholar
  66. 66.
    Summers RW, Elliott DE, Urban JF, Jr., Thompson RA, Weinstock JV (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128: 825–832PubMedCrossRefGoogle Scholar
  67. 67.
    Mortimer K, Brown A, Feary J, Jagger C, Lewis S, Antoniak M, Pritchard D, Britton J (2006) Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am J Trop Med Hyg 75: 914–920PubMedGoogle Scholar
  68. 68.
    Wilson MS, Maizels RM (2006) Regulatory T cells induced by parasites and the modulation of allergic responses. Chem Immunol Allergy 90: 176–195PubMedCrossRefGoogle Scholar
  69. 69.
    Fallon PG, Mangan NE (2007) Suppression of Th2-type allergic reactions by helminth infection. Nature Reviews Immunology 7: 220–230PubMedCrossRefGoogle Scholar
  70. 70.
    Bashir ME, Andersen P, Fuss IJ, Shi HN, Nagler-Anderson C (2002) An enteric helminth infection protects against an allergic response to dietary antigen. J Immunol 169: 3284–3292PubMedGoogle Scholar
  71. 71.
    Wang CC, Nolan TJ, Schad GA, Abraham D (2001) Infection of mice with the helminth Strongyloides stercoralis suppresses pulmonary allergic responses to ovalbumin. Clin Exp Allergy 31: 495–503PubMedCrossRefGoogle Scholar
  72. 72.
    Wohleben G, Trujillo C, Muller J, Ritze Y, Grunewald S, Tatsch U, Erb KJ (2004) Helminth infection modulates the development of allergen-induced airway inflammation. Int Immunol 16: 585–596CrossRefGoogle Scholar
  73. 73.
    Dittrich AM, Erbacher A, Specht S, Diesner F, Krokowski M, Avagyan A, Stock P, Ahrens B, Hoffmann WH, Hoerauf A et al (2008) Helminth infection with Litomosoides sigmodontis induces regulatory T cells and inhibits allergic sensitization, airway inflammation, and hyperreactivity in a murine asthma model. J Immunol 180: 1792–1799PubMedGoogle Scholar
  74. 74.
    Mangan NE, Fallon RE, Smith P, van Rooijen N, McKenzie AN, Fallon PG (2004) Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol 173: 6346–6356PubMedGoogle Scholar
  75. 75.
    Dunne DW, Cooke A (2005) A worm’s eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 5: 420–426PubMedCrossRefGoogle Scholar
  76. 76.
    Cooke A, Tonks P, Jones FM, O’Shea H, Hutchings P, Fulford AJ, Dunne DW (1999) Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunology 21: 169–176PubMedCrossRefGoogle Scholar
  77. 77.
    Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, Cooke A (2003) Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 33: 1439–1449PubMedCrossRefGoogle Scholar
  78. 78.
    Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF Jr, Weinstock JV (2003) Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 284: G385–391PubMedGoogle Scholar
  79. 79.
    Mo HM, Liu WQ, Lei JH, Cheng YL, Wang CZ, Li YL (2007) Schistosoma japonicum eggs modulate the activity of CD4+ CD25+ Tregs and prevent development of colitis in mice. Exp Parasitol 116: 385–389PubMedCrossRefGoogle Scholar
  80. 80.
    Smith P, Mangan NE, Walsh CM, Fallon RE, McKenzie ANJ, van Rooijen N, Fallon PG (2007) Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 178: 4557–4566PubMedGoogle Scholar
  81. 81.
    Sewell D, Qing Z, Reinke E, Elliot D, Weinstock J, Sandor M, Fabry Z (2003) Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 15: 59–69PubMedCrossRefGoogle Scholar
  82. 82.
    La Flamme AC, Ruddenklau K, Backstrom BT (2003) Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 71: 4996–5004PubMedCrossRefGoogle Scholar
  83. 83.
    Schnoeller C, Rausch S, Pillai S, Avagyan A, Wittig BM, Loddenkemper C, Hamann A, Hamelmann E, Lucius R, Hartmann S (2008) A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 180: 4265–4272PubMedGoogle Scholar
  84. 84.
    Melendez AJ, Harnett MM, Pushparaj PN, Wong WSF, Tay HK, McSharry CP, Harnett W (2007) Inhibition of FceRI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat Med 13: 1375–1381PubMedCrossRefGoogle Scholar
  85. 85.
    Harnett W, Harnett MM (2008) Therapeutic immunomodulators from nematode parasites. Expert Rev Mol Med 10: e 18CrossRefGoogle Scholar
  86. 86.
    van der Kleij D, Latz E, Brouwers JFHM, Kruize YCM, Schmitz M, Kurt-Jones EA, Espevik T, de Jong EC, Kapsenberg ML, Golenbock DT et al (2002) A novel host—parasite lipid cross talk: schistosomal lysophosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J Biol Chem 277: 48122–48129PubMedCrossRefGoogle Scholar
  87. 87.
    Gale EA (2002) A missing link in the hygiene hypothesis? Diabetologia 45: 588–594PubMedCrossRefGoogle Scholar
  88. 88.
    Noverr MC, Huffnagle GB (2005) The ‘microflora hypothesis’ of allergic diseases. Clin Exp Allergy 35: 1511–1520PubMedCrossRefGoogle Scholar
  89. 89.
    Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4: 478–485PubMedCrossRefGoogle Scholar
  90. 90.
    Noverr MC, Huffnagle GB (2004) Does the microbiota regulate immune responses outside the gut? Trends Microbiol 12: 562–568PubMedCrossRefGoogle Scholar
  91. 91.
    Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307: 1915–1920PubMedCrossRefGoogle Scholar
  92. 92.
    Pamer EG (2007) Immune responses to commensal and environmental microbes. Nat Immunol 8: 1173–1178PubMedCrossRefGoogle Scholar
  93. 93.
    Pédron T, Sansonetti P (2008) Commensals, bacterial pathogens and intestinal inflammation: an intriguing menage a trois. Cell Host Microbe 3: 344–347PubMedCrossRefGoogle Scholar
  94. 94.
    Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5: 104–112PubMedCrossRefGoogle Scholar
  95. 95.
    Tien MT, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppee JY, Bourdet-Sicard R, Sansonetti PJ, Pedron T (2006) Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176: 1228–1237PubMedGoogle Scholar
  96. 96.
    Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition nition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229–241PubMedCrossRefGoogle Scholar
  97. 97.
    Lievin-Le Moal V, Servin AL (2006) The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 19: 315–337CrossRefGoogle Scholar
  98. 98.
    Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM, Nespoli A, Viale G, Allavena P, Rescigno M (2005) Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 6: 507–514PubMedCrossRefGoogle Scholar
  99. 99.
    MacPherson AJ, Uhr T (2004) Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303: 1662–1665PubMedCrossRefGoogle Scholar
  100. 100.
    Peterson DA, McNulty NP, Guruge JL, Gordon JI (2007) IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2: 328–339PubMedCrossRefGoogle Scholar
  101. 101.
    Zaph C, Du Y, Saenz SA, Nair MG, Perrigoue JG, Taylor BC, Troy AE, Kobuley DE, Kastelein RA, Cua DJ et al (2008) Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 205: 2191–2198PubMedCrossRefGoogle Scholar
  102. 102.
    Ivanov, II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR (2008) Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4: 337–349PubMedCrossRefGoogle Scholar
  103. 103.
    Mazmanian SK, Kasper DL (2006) The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 6: 849–858PubMedCrossRefGoogle Scholar
  104. 104.
    Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122: 107–118PubMedCrossRefGoogle Scholar
  105. 105.
    Wang Q, McLoughlin RM, Cobb BA, Charrel-Dennis M, Zaleski KJ, Golenbock D, Tzianabos AO, Kasper DL (2006) A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J. Exp Med 203: 2853–2863PubMedCrossRefGoogle Scholar
  106. 106.
    Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453: 620–625PubMedCrossRefGoogle Scholar
  107. 107.
    Fiocchi C (2005) One commensal bacterial molecule — all we need for health?. N Engl J Med 353: 2078–2080PubMedCrossRefGoogle Scholar
  108. 108.
    Bjorksten B, Naaber P, Sepp E, Mikelsaar M (1999) The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 29: 342–346PubMedCrossRefGoogle Scholar
  109. 109.
    Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M (2003) Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 111: 587–591PubMedCrossRefGoogle Scholar
  110. 110.
    Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076–1079PubMedCrossRefGoogle Scholar
  111. 111.
    Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, Adams H, van Ree R, Stobberingh EE (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56: 661–667PubMedCrossRefGoogle Scholar
  112. 112.
    Alm JS, Swartz J, Bjorksten B, Engstrand L, Engstrom J, Kuhn I, Lilja G, Mollby R, Norin E, Pershagen G et al (2002) An anthroposophic lifestyle and intestinal microflora in infancy. Pediatr Allergy Immunol 13: 402–411PubMedCrossRefGoogle Scholar
  113. 113.
    Alm B, Erdes L, Mollborg P, Pettersson R, Norvenius SG, Aberg N, Wennergren G (2008) Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 121: 697–702PubMedCrossRefGoogle Scholar
  114. 114.
    Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J (2008) A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 122: 788–794PubMedCrossRefGoogle Scholar
  115. 115.
    Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361: 1869–1871PubMedCrossRefGoogle Scholar
  116. 116.
    Kalliomaki M, Salminen S, Poussa T, Isolauri E (2007) Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 119: 1019–1021PubMedCrossRefGoogle Scholar
  117. 117.
    Kopp MV, Hennemuth I, Heinzmann A, Urbanek R (2008) Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121: e850–856PubMedCrossRefGoogle Scholar
  118. 118.
    Taylor AL, Hale J, Hales BJ, Dunstan JA, Thomas WR, Prescott SL (2007) FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth. Pediatr Allergy Immunol 18: 10–19PubMedCrossRefGoogle Scholar
  119. 119.
    Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M (2005) Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60: 494–500PubMedCrossRefGoogle Scholar
  120. 120.
    Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB (2005) Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun 73: 30–38PubMedCrossRefGoogle Scholar
  121. 121.
    Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, Ahrens B, Groneberg DA, Wahn U, Hamelmann E (2007) Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 37: 498–505PubMedCrossRefGoogle Scholar
  122. 122.
    Repa A, Grangette C, Daniel C, Hochreiter R, Hoffmann-Sommergruber K, Thalhamer J, Kraft D, Breiteneder H, Mercenier A, Wiedermann U (2003) Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 22: 87–95PubMedCrossRefGoogle Scholar
  123. 123.
    Daniel C, Repa A, Mercenier A, Wiedermann U, Wells J (2007) The European LABDEL project and its relevance to the prevention and treatment of allergies. Allergy 62: 1237–1242PubMedCrossRefGoogle Scholar
  124. 124.
    Schabussova I, Wiedermann U (2008) Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases. Curr Opin Allergy Clin Immunol 8: 557–564PubMedCrossRefGoogle Scholar
  125. 125.
    Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M (2003) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J Immunol 174: 3237–3246Google Scholar
  126. 126.
    Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y et al (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115: 1260–1267PubMedCrossRefGoogle Scholar
  127. 127.
    Foligne B, Zoumpopoulou G, Dewulf J, Ben Younes A, Chareyre F, Sirard JC, Pot B, Grangette C (2007) A key role of dendritic cells in probiotic functionality. PLoS ONE 2: e313PubMedCrossRefGoogle Scholar
  128. 128.
    Forsythe P, Inman MD, Bienenstock J (2007) Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 175: 561–569PubMedCrossRefGoogle Scholar
  129. 129.
    O’Mahony C, Scully P, O’Mahony D, Murphy S, O’Brien F, Lyons A, Sherlock G, MacSharry J, Kiely B, Shanahan F et al (2008) Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 4: e1000112PubMedCrossRefGoogle Scholar
  130. 130.
    Hall JA, Bouladoux N, Sun CM, Wohlfert EA, Blank RB, Zhu Q, Grigg ME, Berzofsky JA, Belkaid Y (2008) Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29: 637–649PubMedCrossRefGoogle Scholar
  131. 131.
    Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S et al (2006) Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8: 1327–1336PubMedCrossRefGoogle Scholar
  132. 132.
    Lauener RP, Birchler T, Adamski J, Braun-Fahrlander C, Bufe A, Herz U, von Mutius E, Nowak D, Riedler J, Waser M et al (2002) Expression of CD14 and Toll-like receptor 2 in farmers’ and non-farmers’ children. Lancet 360: 465–466PubMedCrossRefGoogle Scholar
  133. 133.
    Horner AA, Raz E (2003) Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands. Curr Opin Immunol 15: 614–619PubMedCrossRefGoogle Scholar
  134. 134.
    Fageras Bottcher M, Hmani-Aifa M, Lindstrom A, Jenmalm MC, Mai XM, Nilsson L, Zdolsek HA, Bjorksten B, Soderkvist P, Vaarala O (2004) A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 114: 561–567PubMedCrossRefGoogle Scholar
  135. 135.
    Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrlander C, Nowak D, Martinez FD (2004) Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 113: 482–488PubMedCrossRefGoogle Scholar
  136. 136.
    Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD (1999) A Polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20: 976–983PubMedGoogle Scholar
  137. 137.
    Koppelman GH, Reijmerink NE, Colin Stine O, Howard TD, Whittaker PA, Meyers DA, Postma DS, Bleecker ER (2001) Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 163: 965–969PubMedGoogle Scholar
  138. 138.
    Simpson A, John SL, Jury F, Niven R, Woodcock A, Ollier WE, Custovic A (2006) Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. Am J Respir Crit Care Med 174: 386–392PubMedCrossRefGoogle Scholar
  139. 139.
    Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD, Liu AH (2000) Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 355: 1680–1683PubMedCrossRefGoogle Scholar
  140. 140.
    Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K (2002) Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196: 1645–1651PubMedCrossRefGoogle Scholar
  141. 141.
    Tulic MK, Fiset PO, Manoukian JJ, Frenkiel S, Lavigne F, Eidelman DH, Hamid Q (2004) Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not a dults. Lancet 363: 1689–1697PubMedCrossRefGoogle Scholar
  142. 142.
    Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B (2007) Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 8: 1086–1094PubMedCrossRefGoogle Scholar
  143. 143.
    Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204: 1775–1785PubMedCrossRefGoogle Scholar
  144. 144.
    Rescigno M, Matteoli G (2008) Lamina propria dendritic cells: for whom the bell TOLLs? Eur J Immunol 38: 1483–1486PubMedCrossRefGoogle Scholar
  145. 145.
    Bashir ME, Louie S, Shi HN, Nagler-Anderson C (2004) Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J Immunol 172: 6978–6987PubMedGoogle Scholar
  146. 146.
    Debarry J, Garn H, Hanuszkiewicz A, Dickgreber N, Blumer N, von Mutius E, Bufe A, Gatermann S, Renz H, Holst O et al (2007) Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol 119: 1514–1521PubMedCrossRefGoogle Scholar
  147. 147.
    Dogi CA, Galdeano CM, Perdigon G (2008) Gut immune stimulation by non pathogenic Gram(+) and Gram(−) bacteria. Comparison with a probiotic strain. Cytokine 41: 223–231PubMedCrossRefGoogle Scholar
  148. 148.
    Nair MG, Gallagher IJ, Taylor MD, Loke P, Coulson PS, Wilson RA, Maizels RM, Allen JE (2005) Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infection and Immunity 73: 385–394PubMedCrossRefGoogle Scholar
  149. 149.
    Loke P, MacDonald AS, Robb A, Maizels RM, Allen JE (2000) Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell to cell contact. Eur J Immunol 30: 2669–2678PubMedCrossRefGoogle Scholar
  150. 150.
    Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H et al (2004) Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 Cells. J Exp Med 199: 1567–1575PubMedCrossRefGoogle Scholar
  151. 151.
    Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, Knol EF, Behrendt H, Blaser K, Akdis CA (2006) Absense of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 117: 176–183PubMedCrossRefGoogle Scholar
  152. 152.
    Yazdanbakhsh M, Kremsner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296: 490–494PubMedCrossRefGoogle Scholar
  153. 153.
    Maizels RM (2005) Infections and allergy—helminths, hygiene and host immune regulation. Curr Opin Immunol 17: 656–661PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2009

Authors and Affiliations

  • Rick M. Maizels
    • 1
  • Ursula Wiedermann
    • 2
  1. 1.Institute of Immunology and Infection ResearchEdinburghUK
  2. 2.Department of Specific Prophylaxis and Tropical MedicineMedical University of ViennaViennaAustria

Personalised recommendations